Cellyan FY26 net loss widens to $1.14 million; revenue falls 34% to $13.43 millionPUBT·Aug 7 at 03:32 PMHKPD-1.86%
Cellyan Biotechnology flags delay in filing annual Form 20-F for FY ended March 31, 2026PUBT·Jul 31 at 03:31 PMHKPD-1.86%
12 Industrials Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 27 at 07:05 AMWETO+199.15%PN+6.44%
Capital Reallocation on the Fringes: Signals of Strategic PivotsGlobal Report·Jul 26 at 04:14 AMGNRC+0.89%BWEN-2.04%
Niche U.S. Equities Face Commercial and Regulatory Tests in Mid-2026Global Report·Jul 25 at 04:18 AMAUR-0.29%VSME-6.92%
The Market's Island of Misfit Toys: Separating the Builders from the FakersGlobal Report·Jul 25 at 04:13 AMKVUE-2.14%AUR-0.29%
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy MiddleGlobal Report·Jul 24 at 04:13 AMNLST+2.55%HKPD-1.86%
From AI Pivots to Reverse Splits: U.S. Micro-Caps Embrace Aggressive Restructuring in JulyGlobal Report·Jul 19 at 04:13 AMSDEV-4.85%CRDF-6.10%
12 Industrials Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Jul 17 at 07:05 AMSLND+11.95%CJMB+13.08%
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happenedbenzinga_article·Jul 17 at 12:36 AMHKPD-1.86%
Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.benzinga_article·Jul 16 at 03:34 PMHKPD-1.86%
12 Industrials Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jul 2 at 04:05 PMNCT+6.03%ICON-0.48%
12 Industrials Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jun 23 at 07:05 AMCIIT-3.85%WETO+199.15%
12 Industrials Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jun 10 at 04:05 PMHKPD-1.86%SOARW0.00%
